NCT04230980

Gabapentin for Post-Operative Pain Control and Narcotic Reduction in Scrotal Surgery

The Use of Gabapentin for Post-Operative Pain Control and Narcotic Reduction in Scrotal Surgery

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 74 (actual)
• Sponsor: Weill Medical College of Cornell University · Academic / Other
• Sex: Male
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The use of non-narcotic multi-modal analgesia to be used in the pre-operative, peri-operative and post-operative period to reduce or potentially eliminate narcotic usage following scrotal surgery. Research study results have shown that the use of anti-inflammatories in the peri-operative period reduces both pain and narcotic use. The hypothesis is that adding another agent in the multi-modal pathway will further reduce pain and potentially reduce narcotic usage.

Detailed description

This is a double-blinded, placebo-controlled, randomized trial that will recruit patients categorized into two study arms. Patients in the gabapentin arm will receive gabapentin 600mg taken pre-operatively and 300mg taken three times a day for 3 days, while patients in the placebo arm will receive a placebo drug taken pre-operatively three times a day for 3 days.

Conditions

• Non-obstructive Azoospermia

Interventions

Type	Name	Description
DRUG	Gabapentin	Gabapentin 600mg tablet
DRUG	Placebo	Placebo tablet

Timeline

• Start date: 2020-07-28
• Primary completion: 2022-11-28
• Completion: 2022-12-16
• First posted: 2020-01-18
• Last updated: 2023-10-18
• Results posted: 2023-10-18

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study